REVELATION BIOSCIENCES, INC. Cash and Restricted Cash
REVELATION BIOSCIENCES, INC. (REVB) had Cash and Restricted Cash of $11.48 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11.48M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $14.11M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.70M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.71M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $11.48M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $14.11M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $10.70M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $12.71M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $5.17M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $3.70M 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $6.50M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $6.54M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $12.07M 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $14.55M 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $11.99M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $13.99M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $15.71M 10-Q/A · filed 2024-09-23 | |
| 2023-03-31 | $17.70M 10-Q/A · filed 2024-09-23 | |
| 2022-12-31 | $5.25M 10-K · filed 2025-03-06 | |
| 2022-09-30 | $6.20M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $3.48M 10-Q · filed 2023-08-11 | |
| 2022-03-31 | $7.19M 10-Q · filed 2023-05-22 | |
| 2021-12-31 | $1.27M 10-K/A · filed 2024-09-23 | $78.53K 10-K · filed 2022-04-15 |
| 2021-09-30 | $4.14M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $6.37M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $10.02M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $4.49M 10-K · filed 2023-03-30 | $11.73K 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |